Protein Array Shops Predict Buoyant Market Despite Weak NIH Budget, Pharma Stinginess | GenomeWeb
The month of January saw the debut of a variety of protein array platforms intended to be used by pharmaceutical and biotech companies as well as the research community. Companies as diverse as GenTel Biosciences, Decision Biomarkers, and Plexera launched or pledged to launch protein array products that could be used in both biomarker discovery and clinical trials.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.